• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管侵犯在无功能性胰腺神经内分泌肿瘤患者中的重要性。

The importance of microvascular invasion in patients with non-functioning pancreatic neuroendocrine neoplasm.

作者信息

Izumo Wataru, Higuchi Ryota, Furukawa Toru, Shiihara Masahiro, Uemura Shuichiro, Yazawa Takehisa, Yamamoto Masakazu, Honda Goro

机构信息

Department of Surgery, Institute of Gastroenterology, Tokyo Womens Medical University, 8-1 Kawada-cho, Tokyo, Shinjuku City, Japan.

Division of Gastroenterological Surgery, Tokyo Womens Medical University Yachiyo Medical Center, Yachiyo City, Chiba, Japan.

出版信息

Langenbecks Arch Surg. 2024 Dec 16;410(1):8. doi: 10.1007/s00423-024-03563-x.

DOI:10.1007/s00423-024-03563-x
PMID:39676094
Abstract

BACKGROUND/OBJECTIVES: The oncological importance of lymphatic, microvascular, and perineural invasions and their association with outcomes in patients with non-functioning pancreatic neuroendocrine neoplasm (NF-PanNEN) remains unclear. We aimed to investigate the role of these factors in the prognosis of patients with NF-PanNEN.

METHODS

We retrospectively analyzed 115 patients who underwent curative resection and were pathologically and clinically diagnosed with NF-PanNEN. We evaluated the relationship between clinicopathological factors and recurrence.

RESULTS

Thirty (26%), 38 (33%), and 11 (10%) patients had lymphatic, microvascular, and nerve invasions, respectively. Twenty-one patients (18%) experienced recurrence, with a median time to recurrence of 2.6 years (range: 0.3-8.2). The 3-, 5-, and 10-year recurrence-free survival (RFS) rates were 88.3%, 84.4%, and 79.1%, respectively. In multivariate analyses, World Health Organization Grade G2-3 (vs. G1, hazard ratio (HR): 16.2), T factor T3-4 (vs. T1-2, HR: 5.2), and the presence of microvascular invasion (vs. absence, HR: 5.6) were significant risk factors for RFS. When these risk factors were assigned as risk score of three, one, and one points depending on the HR, the 5-year recurrence rates in patients with risk score groups 0-1 and 2-5 were 98.6% and 53.3%, (P < 0.001). Moreover, only the presence of microvascular invasion significantly increased the likelihood of recurrence within 3 years.

CONCLUSIONS

The presence of microvascular invasion is an independent risk factor for recurrence in patients with NF-PanNEN. Our risk scoring system, which includes "the presence of microvascular invasion," may be useful for predicting recurrence.

摘要

背景/目的:淋巴管、微血管和神经侵犯在无功能性胰腺神经内分泌肿瘤(NF-PanNEN)患者中的肿瘤学重要性及其与预后的关系仍不明确。我们旨在研究这些因素在NF-PanNEN患者预后中的作用。

方法

我们回顾性分析了115例行根治性切除术且经病理和临床诊断为NF-PanNEN的患者。我们评估了临床病理因素与复发之间的关系。

结果

分别有30例(26%)、38例(33%)和11例(10%)患者存在淋巴管、微血管和神经侵犯。21例(18%)患者出现复发,复发的中位时间为2.6年(范围:0.3 - 8.2年)。3年、5年和10年无复发生存率(RFS)分别为88.3%、84.4%和79.1%。在多因素分析中,世界卫生组织G2 - 3级(与G1级相比,风险比(HR):16.2)、T分期T3 - 4期(与T1 - 2期相比,HR:5.2)以及微血管侵犯的存在(与无微血管侵犯相比,HR:5.6)是RFS的显著危险因素。当根据HR将这些危险因素分别赋值为3分、1分和1分作为风险评分时,风险评分组0 - 1分和2 - 5分患者的5年复发率分别为98.6%和53.3%(P < 0.001)。此外,仅微血管侵犯的存在显著增加了3年内复发的可能性。

结论

微血管侵犯的存在是NF-PanNEN患者复发的独立危险因素。我们包含“微血管侵犯的存在”的风险评分系统可能有助于预测复发。

相似文献

1
The importance of microvascular invasion in patients with non-functioning pancreatic neuroendocrine neoplasm.微血管侵犯在无功能性胰腺神经内分泌肿瘤患者中的重要性。
Langenbecks Arch Surg. 2024 Dec 16;410(1):8. doi: 10.1007/s00423-024-03563-x.
2
Evaluation of the details and importance of lymphatic, microvascular, and perineural invasion in patients with non-functioning pancreatic neuroendocrine neoplasms based on tumor size and the 2022 World Health Organization classification: a 23-year retrospective analysis.基于肿瘤大小和2022年世界卫生组织分类对无功能性胰腺神经内分泌肿瘤患者的淋巴管、微血管和神经周围侵犯的细节及重要性进行评估:一项23年的回顾性分析
World J Surg Oncol. 2025 Mar 8;23(1):79. doi: 10.1186/s12957-025-03734-0.
3
Evaluation of the Significance of Lymphatic, Microvascular and Perineural Invasion in Patients With Pancreatic Neuroendocrine Neoplasms.胰腺神经内分泌肿瘤患者淋巴管、微血管和神经周围侵犯的意义评估
Cancer Diagn Progn. 2022 Mar 3;2(2):150-159. doi: 10.21873/cdp.10089. eCollection 2022 Mar-Apr.
4
Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.基于新分级分类法的高分化胰腺神经内分泌肿瘤根治性切除术后复发危险因素分析
J Hepatobiliary Pancreat Sci. 2014 Jun;21(6):418-25. doi: 10.1002/jhbp.47. Epub 2013 Oct 20.
5
Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.根治性切除术后胰腺和十二指肠神经内分泌肿瘤复发的比较:单中心分析。
Ann Surg Oncol. 2018 Feb;25(2):528-534. doi: 10.1245/s10434-017-6260-1. Epub 2017 Nov 21.
6
Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.单灶性与多灶性神经内分泌胰腺肿瘤的最佳手术管理:一项队列研究。
World J Surg Oncol. 2024 Apr 26;22(1):115. doi: 10.1186/s12957-024-03383-9.
7
Disease-free survival after pancreatectomy for pancreatic neuroendocrine tumors: A 17-year single-center experience of 223 patients.胰十二指肠切除术治疗胰腺神经内分泌肿瘤:223 例患者 17 年单中心经验。
J Gastrointest Surg. 2024 Sep;28(9):1485-1492. doi: 10.1016/j.gassur.2024.06.015. Epub 2024 Jun 19.
8
Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.Ki67 预测胰腺神经内分泌肿瘤的复发和生存。
Ann Surg Oncol. 2018 Aug;25(8):2467-2474. doi: 10.1245/s10434-018-6518-2. Epub 2018 May 22.
9
Venous invasion and lymphatic invasion are correlated with the postoperative prognosis of pancreatic neuroendocrine neoplasm.静脉侵犯和淋巴管侵犯与胰腺神经内分泌肿瘤的术后预后相关。
Surgery. 2023 Feb;173(2):365-372. doi: 10.1016/j.surg.2022.08.009. Epub 2022 Sep 16.
10
Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.症状表现作为胃肠胰神经内分泌肿瘤复发的预测指标:一家机构15年的经验
J Surg Oncol. 2016 Aug;114(2):163-9. doi: 10.1002/jso.24279. Epub 2016 May 8.

引用本文的文献

1
Learning curve of minimally invasive complete mesocolic excision for right-sided colon cancer: a systematic review.右侧结肠癌微创全结肠系膜切除术的学习曲线:一项系统评价
Surg Endosc. 2025 Aug 29. doi: 10.1007/s00464-025-12128-y.
2
Laparoscopic enucleation vs. pancreatectomy for small pancreatic neuroendocrine neoplasms: long-term functional and oncological outcomes.腹腔镜剜除术与胰腺切除术治疗小胰腺神经内分泌肿瘤:长期功能和肿瘤学结局
Surg Endosc. 2025 Aug 29. doi: 10.1007/s00464-025-11935-7.

本文引用的文献

1
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.欧洲神经内分泌肿瘤学会(ENETS)2023 年无功能性胰腺神经内分泌肿瘤指南。
J Neuroendocrinol. 2023 Dec;35(12):e13343. doi: 10.1111/jne.13343. Epub 2023 Oct 25.
2
Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan.日本胰腺、胃肠道、肺、支气管或胸腺神经内分泌肿瘤患者全国登记。
Int J Clin Oncol. 2022 May;27(5):840-849. doi: 10.1007/s10147-022-02130-y. Epub 2022 Feb 18.
3
Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lu-Dotatate 联合长效奥曲肽与高剂量长效奥曲肽治疗肠神经内分泌肿瘤患者(NETTER-1):一项开放标签、随机、对照、III 期临床试验的最终总生存和长期安全性结果。
Lancet Oncol. 2021 Dec;22(12):1752-1763. doi: 10.1016/S1470-2045(21)00572-6. Epub 2021 Nov 15.
4
Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.功能性胰腺神经内分泌肿瘤(NF-PanNENs)根治性手术后疾病复发的预测因素:系统评价和荟萃分析。
J Endocrinol Invest. 2022 Apr;45(4):705-718. doi: 10.1007/s40618-021-01705-2. Epub 2021 Nov 13.
5
International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.国际验证用于预测 1 级和 2 级无功能胰腺神经内分泌肿瘤切除后复发的列线图。
Neuroendocrinology. 2022;112(6):571-579. doi: 10.1159/000518757. Epub 2021 Jul 29.
6
The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.患者小的无功能性胰腺神经内分泌肿瘤的临床病理和手术特点。
ANZ J Surg. 2021 Jul;91(7-8):E484-E492. doi: 10.1111/ans.17055. Epub 2021 Jul 21.
7
Increased neutrophil-lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification.基于 2017 年世界卫生组织分类,升高的中性粒细胞与淋巴细胞比值可预测分化良好的胰腺神经内分泌肿瘤患者的复发。
BMC Surg. 2021 Mar 31;21(1):176. doi: 10.1186/s12893-021-01178-3.
8
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤监测和医学管理的共识指南。
Pancreas. 2020 Aug;49(7):863-881. doi: 10.1097/MPA.0000000000001597.
9
Evaluation of the Site and Frequency of Lymph Node Metastasis with Non-Functioning Pancreatic Neuroendocrine Tumor.无功能性胰腺神经内分泌肿瘤淋巴结转移部位及频率的评估
Eur Surg Res. 2019;60(5-6):219-228. doi: 10.1159/000504410. Epub 2019 Nov 15.
10
Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages.中性粒细胞-淋巴细胞比值对可切除胰腺神经内分泌肿瘤的预后意义,特别关注肿瘤相关巨噬细胞。
Pancreatology. 2019 Sep;19(6):897-902. doi: 10.1016/j.pan.2019.08.003. Epub 2019 Aug 7.